FDA Approved: TRI-LUMA — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for Tri-Luma from Galderma Laboratories, approving changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)

Snippet

SUPPL AP for TRI-LUMA (FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN)